Hoover Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$713K Sell
5,745
-352
-6% -$44.2K 0.13% 66
2021
Q1
$763K Buy
6,097
+31
+0.5% +$3.63K 0.14% 59
2020
Q4
$714K Buy
6,066
+171
+3% +$18.8K 0.18% 49
2020
Q3
$613K Hold
5,895
0.2% 43
2020
Q2
$541K Sell
5,895
-20
-0.3% -$1.92K 0.21% 45
2020
Q1
$533K Buy
5,915
+20
+0.3% +$2.13K 0.29% 35
2019
Q4
$669K Hold
5,895
0.33% 38
2019
Q3
$640K Hold
5,895
0.57% 24
2019
Q2
$574K Hold
5,895
0.53% 24
2019
Q1
$537K Hold
5,895
0.51% 26
2018
Q4
$536K Buy
+5,895
New +$551K 0.59% 24

Other funds holding MDT

Hoover Financial Advisors's MDT Position: Q2 2021 in Review

Hoover Financial Advisors reduced its Medtronic (MDT) stake by 5.8% in Q2 2021, selling an estimated $44.2K and leaving 5,745 shares worth $713K. The position accounts for 0.13% of the portfolio, ranked #66.

Hoover Financial Advisors first reported a position in MDT in Q4 2018 and has held it in 11 quarters since. The position peaked at $763K in Q1 2021. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • Hoover Financial Advisors held 5,745 shares of Medtronic worth $713K as of Q2 2021.
  • Hoover Financial Advisors sold 352 Medtronic shares in Q2 2021, an estimated $44.2K.
  • Medtronic made up 0.13% of Hoover Financial Advisors's portfolio in Q2 2021, its #66 holding.
  • Hoover Financial Advisors first reported a position in Medtronic in Q4 2018 and has held it in 11 quarters since.
  • Hoover Financial Advisors's Medtronic position peaked at $763K in Q1 2021.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.